| The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis EA Kotteas, P Boulas, I Gkiozos, S Tsagkouli, G Tsoukalas, KN Syrigos Anticancer research 34 (9), 4665-4672, 2014 | 115 | 2014 |
| Management and outcomes in metaplastic breast cancer IG Tzanninis, EA Kotteas, I Ntanasis-Stathopoulos, P Kontogianni, ... Clinical breast cancer 16 (6), 437-443, 2016 | 94 | 2016 |
| Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol E Syrigou, I Dannos, E Kotteas, N Makrilia, I Tourkantonis, K Dilana, ... International archives of allergy and immunology 156 (3), 320-324, 2011 | 54 | 2011 |
| CD24: a novel target for cancer immunotherapy E Panagiotou, NK Syrigos, A Charpidou, E Kotteas, IA Vathiotis Journal of Personalized Medicine 12 (8), 1235, 2022 | 49 | 2022 |
| Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer‐associated … K Syrigos, D Grapsa, R Sangare, I Evmorfiadis, AK Larsen, P Van Dreden, ... The Oncologist 23 (11), 1372-1381, 2018 | 48 | 2018 |
| Immune checkpoint inhibitor-related pneumonitis G Gomatou, V Tzilas, E Kotteas, K Syrigos, D Bouros Respiration 99 (11), 932-942, 2021 | 44 | 2021 |
| Targeted therapy for oesophageal cancer: an overview KN Syrigos, A Zalonis, E Kotteas, MW Saif Cancer and Metastasis Reviews 27, 273-288, 2008 | 42 | 2008 |
| Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors EA Kotteas, KN Syrigos, MW Saif OncoTargets and therapy, 699-704, 2016 | 40 | 2016 |
| Bcl-2 pathway inhibition in solid tumors: a review of clinical trials I Ploumaki, E Triantafyllou, IA Koumprentziotis, K Karampinos, ... Clinical and Translational Oncology 25 (6), 1554-1578, 2023 | 35 | 2023 |
| Tumor dormancy: implications for invasion and metastasis G Gomatou, N Syrigos, IA Vathiotis, EA Kotteas International journal of molecular sciences 22 (9), 4862, 2021 | 34 | 2021 |
| Immunotherapy for pancreatic cancer E Kotteas, MW Saif, K Syrigos Journal of cancer research and clinical oncology 142, 1795-1805, 2016 | 33 | 2016 |
| Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it M Drizou, EA Kotteas, N Syrigos Clinical and Translational Oncology 19, 658-666, 2017 | 32 | 2017 |
| Optimizing diet and nutrition for cancer survivors: A review N Mourouti, DB Panagiotakos, EA Kotteas, KN Syrigos Maturitas 105, 33-36, 2017 | 31 | 2017 |
| Osimertinib resistance: molecular mechanisms and emerging treatment options G Gomatou, N Syrigos, E Kotteas Cancers 15 (3), 841, 2023 | 30 | 2023 |
| Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group E Fountzilas, S Lampaki, GA Koliou, A Koumarianou, S Levva, ... Cancer Immunology, Immunotherapy 71 (2), 327-337, 2022 | 30 | 2022 |
| Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience E Kotteas, C Alamara, M Kiagia, K Pantazopoulos, A Boufas, A Provata, ... Anticancer research 28 (1B), 529-533, 2008 | 29 | 2008 |
| Neuroendocrine Merkel cell nodal carcinoma of unknown primary site: management and outcomes of a rare entity EA Kotteas, N Pavlidis Critical Reviews in Oncology/Hematology 94 (1), 116-121, 2015 | 28 | 2015 |
| Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors G Gomatou, I Trontzas, S Ioannou, M Drizou, N Syrigos, E Kotteas Molecular biology reports 48, 915-925, 2021 | 26 | 2021 |
| Malignant superior vena cava syndrome: state of the art V Patriarcheas, M Grammoustianou, N Ptohis, I Thanou, M Kostis, ... Cureus 14 (1), 2022 | 23 | 2022 |
| The emerging role of tyrosine kinase inhibitors in ovarian cancer treatment: a systematic review I Ntanasis-Stathopoulos, G Fotopoulos, IG Tzanninis, EA Kotteas Cancer investigation 34 (7), 313-339, 2016 | 23 | 2016 |
SYRIGOS KONSTANTINOS N.NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, GREECE在 med.uoa.gr 的电子邮件经过验证
